Yoshitaka Hosaka

611 total citations
40 papers, 499 citations indexed

About

Yoshitaka Hosaka is a scholar working on Hematology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yoshitaka Hosaka has authored 40 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 10 papers in Genetics and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yoshitaka Hosaka's work include Blood Coagulation and Thrombosis Mechanisms (16 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers) and Atrial Fibrillation Management and Outcomes (7 papers). Yoshitaka Hosaka is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (16 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers) and Atrial Fibrillation Management and Outcomes (7 papers). Yoshitaka Hosaka collaborates with scholars based in Japan. Yoshitaka Hosaka's co-authors include Yasuo Takahashi, Hidemi Ishii, Masaki Nakamura, Kamon Shirakawa, Hidenori Mochizuki, Shoji Furusako, Toshiyuki Higuchi, Hiromi Niina, Yutaka Miyazaki and Shuhei Ohnishi and has published in prestigious journals such as Journal of Clinical Investigation, Blood and European Journal of Pharmacology.

In The Last Decade

Yoshitaka Hosaka

39 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshitaka Hosaka Japan 13 231 124 94 76 75 40 499
Susanne Zieseniss Germany 5 217 0.9× 81 0.7× 178 1.9× 81 1.1× 36 0.5× 5 495
K Deguchi Japan 14 217 0.9× 82 0.7× 45 0.5× 109 1.4× 45 0.6× 32 439
ML Rand Canada 13 314 1.4× 131 1.1× 78 0.8× 87 1.1× 30 0.4× 20 615
José A. López United States 10 237 1.0× 116 0.9× 161 1.7× 65 0.9× 24 0.3× 19 500
Sigrun Badrnya Austria 10 153 0.7× 124 1.0× 196 2.1× 93 1.2× 69 0.9× 16 593
Anh T. P. Ngo United States 14 147 0.6× 87 0.7× 109 1.2× 36 0.5× 40 0.5× 29 398
Kenneth J. Clemetson Switzerland 7 407 1.8× 135 1.1× 101 1.1× 86 1.1× 27 0.4× 8 606
Karl Egan Ireland 15 194 0.8× 79 0.6× 116 1.2× 29 0.4× 30 0.4× 29 554
Darlene J. Elias United States 13 97 0.4× 59 0.5× 150 1.6× 72 0.9× 40 0.5× 28 503
Ildikó Beke Debreceni Hungary 10 119 0.5× 59 0.5× 73 0.8× 51 0.7× 36 0.5× 30 299

Countries citing papers authored by Yoshitaka Hosaka

Since Specialization
Citations

This map shows the geographic impact of Yoshitaka Hosaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshitaka Hosaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshitaka Hosaka more than expected).

Fields of papers citing papers by Yoshitaka Hosaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshitaka Hosaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshitaka Hosaka. The network helps show where Yoshitaka Hosaka may publish in the future.

Co-authorship network of co-authors of Yoshitaka Hosaka

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshitaka Hosaka. A scholar is included among the top collaborators of Yoshitaka Hosaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshitaka Hosaka. Yoshitaka Hosaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hosaka, Yoshitaka, et al.. (2015). Establishment of immunoassay for platelet-derived soluble glycoprotein VI, a novel platelet marker. Journal of Immunological Methods. 418. 52–60. 2 indexed citations
2.
Hosaka, Yoshitaka, et al.. (2014). Properties of soluble glycoprotein VI, a potential platelet activation biomarker. Platelets. 26(8). 745–750. 7 indexed citations
3.
Yamashita, Yoshiki, Hideo Wada, Makoto Ikejiri, et al.. (2013). Elevated plasma levels of soluble platelet glycoprotein VI (GPVI) in patients with thrombotic microangiopathy. Thrombosis Research. 133(3). 440–444. 29 indexed citations
4.
Takayama, Hiroshi, et al.. (2008). A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor γ-chain complex. Journal of Clinical Investigation. 118(5). 1785–1795. 50 indexed citations
5.
Nakamura, Masaki, et al.. (2008). Early elevation of plasma soluble CD14 subtype, a novel biomarker for sepsis, in a rabbit cecal ligation and puncture model. Critical Care. 12(Suppl 2). P194–P194. 25 indexed citations
6.
Nakamura, Masaki, Yusuke Shimizu, Yasuko Sato, et al.. (2007). Toll-like receptor 4 signal transduction inhibitor, M62812, suppresses endothelial cell and leukocyte activation and prevents lethal septic shock in mice. European Journal of Pharmacology. 569(3). 237–243. 24 indexed citations
7.
Ishibashi, Hiroyuki, Hiromichi Niikawa, Yoshitaka Hosaka, et al.. (2005). [Primary lung cancer incidentally diagnosed in lung biopsy for diffuse pulmonary disease].. PubMed. 58(9). 813–7. 1 indexed citations
8.
Hosaka, Yoshitaka, et al.. (2005). Pharmacological characterization of the active synthetic factor Xa inhibitors M55551 and M55165. European Journal of Pharmacology. 529(1-3). 164–171. 3 indexed citations
9.
Hosaka, Yoshitaka, et al.. (2004). In vitro evaluation of cryogen spray cooling exposure on model human skin. Lasers in Surgery and Medicine. 34. 2 indexed citations
10.
Hosaka, Yoshitaka, Yusuke Shimizu, Masaki Nakamura, et al.. (2004). Benzisothiazole derivative inhibits toll-like receptor 4 signal transduction and prevents mice from the lethal shock. Critical Care. 8(Suppl 1). P202–P202. 1 indexed citations
11.
Miyazaki, Yutaka, Manabu Itoh, Atsushi Okamoto, et al.. (2002). Synthesis and Evaluation of 1-Arylsulfonyl-3-piperazinone Derivatives as a Factor Xa Inhibitor. II. Substituent Effect on Biological Activities.. Chemical and Pharmaceutical Bulletin. 50(9). 1187–1194. 23 indexed citations
12.
Kato, Yutaka, Yoshitaka Hosaka, Tomohiro Takahashi, et al.. (2001). Effect of trapidil on effector functions of monocytes related to atherosclerotic plaque. European Journal of Pharmacology. 428(3). 371–379. 5 indexed citations
13.
Muramatsu, Hiroyuki, et al.. (2001). Inhibitory effect of M50054, a novel inhibitor of apoptosis, on anti-Fas-antibody-induced hepatitis and chemotherapy-induced alopecia. European Journal of Pharmacology. 433(1). 37–45. 25 indexed citations
14.
Hosaka, Yoshitaka, et al.. (2000). Inhibition of invasion and experimental metastasis of murine melanoma cells by human soluble thrombomodulin. Cancer Letters. 161(2). 231–240. 37 indexed citations
15.
Imada, Kazunori, et al.. (1999). ATIII-independence of anticoagulant effect of human urinary soluble thrombomodulin. Blood Coagulation & Fibrinolysis. 10(8). 503–512. 2 indexed citations
16.
Takahashi, Yasuo, et al.. (1998). Species Specificity of the Anticoagulant Activity of Human Urinary Soluble Thrombomodulin. Thrombosis Research. 89(4). 187–197. 12 indexed citations
17.
Takahashi, Yasuo, et al.. (1995). Soluble Thrombomodulin Purified from Human Urine Exhibits a Potent Anticoagulant Effect In Vitro and In Vivo. Thrombosis and Haemostasis. 73(5). 805–811. 20 indexed citations
18.
Moriyama, Nobuo, et al.. (1991). LECTINS EXPRESSION OF PARATHYROID GLANDS WITH PRIMARY HYPERPARATHYROIDISM. The Japanese Journal of Urology. 82(4). 572–578. 2 indexed citations
19.
Tanaka, Yasuo, Yoshitaka Hosaka, Norio Nakamura, et al.. (1989). In vivo Antitumor Mechanism of Natural Human Tumor Necrosis Factor Involving a T Cell‐mediated Immunological Route. Japanese Journal of Cancer Research. 80(12). 1161–1164. 9 indexed citations
20.
Nitta, T., et al.. (1985). [Monostotic fibrous dysplasia in the parietal bone: a case report].. PubMed. 13(2). 189–94.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanne Zieseniss Breakdown of academic impact, for papers by K Deguchi Breakdown of academic impact, for papers by ML Rand Breakdown of academic impact, for papers by José A. López Breakdown of academic impact, for papers by Sigrun Badrnya Breakdown of academic impact, for papers by Anh T. P. Ngo Breakdown of academic impact, for papers by Kenneth J. Clemetson Breakdown of academic impact, for papers by Karl Egan Breakdown of academic impact, for papers by Darlene J. Elias Breakdown of academic impact, for papers by Ildikó Beke Debreceni
Rankless by CCL
2026